The US Retina Health Market trajectory reflects a robust commitment to addressing vision loss through cutting-edge therapeutic innovation. With diabetic retinopathy affecting over 9.6 million Americans and vision-threatening forms impacting nearly 1.84 million individuals, the clinical need for advanced interventions continues to intensify. The market benefits from a well-established regulatory...